The Effects Of Herbs on Urine Flow in BPH

Many studies are showing the clear efficacy of these four natural herbs on BPH,

1- Beta-sitosterol

A systematic review study comparing the effectiveness of B-sitosterols with placebo and standard BPH medications on 519 patients showed that in the beta-sitosterol group, there were significant changes in urologic symptom scale scores, and also in urodynamic measures (peak and mean urine flow, residual volume, prostate size).

2-Saw palmetto

The second efficacious herb is Saw palmetto which appears to have efficacy similar to that of medications like finasteride, but it is better tolerated and less expensive. There are no known drug interactions with saw palmetto and reported side effects are minor and rare.

3-Rye Grass Pollen

in one large study of men with BPH who were an average of 68 years old, researchers found that taking 126 mg of pollen extract three times daily for 12 or more weeks was effective at reducing symptom scores on a wide scale, Maximum urine flow rates increased significantly by approximately 18%, and average urine flow rates increased by nearly 18%, while residual urine volume (the amount of urine left in the bladder) after voiding significantly decreased by approximately 45%. In patients who remained on the supplement for more than one year, there was also a 20% decrease in mean prostate volume

4- Pygeum Africanum

Pygeum Africanum is another herb tested to see if it can improve lower urinary tract symptoms (LUTS). One review from 2002 looked at 18 different studies on Pygeum Africanum in men with benign prostatic hyperplasia (BPH). The review found that men reported :

Overall improvement in symptoms, Nighttime urination decreased by 19%, The amount of urine remaining in the bladder decreased by 24%, and The urine flow rate increased by 23%.

So, it seems that when it comes to choosing an effective supplement for BPH, we should consider these four components to be included in that.

References:

-Wilt TJ, Ishani A, Mac Donald R. Pygeum Africanum for benign prostatic hyperplasia. Cochrane. 2002. doi:10.1002/14651858.cd001044.

-Yasumoto R, Kawanishi H, Tsujino T, et al. Clin Ther. 1995 Jan-Feb;17(1):82-7

-https://pubmed.ncbi.nlm.nih.gov/10796740.